Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention
整合辅助合作伙伴服务和系统发育学以预防 HIV 和 HCV
基本信息
- 批准号:10208545
- 负责人:
- 金额:$ 15.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-05-15 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVAddressAdherenceAfrica South of the SaharaAfricanAntibodiesAwardBehaviorBiological AssayBloodCOVID-19COVID-19 pandemicCardiovascular DiseasesCaringCessation of lifeClinicalCommunitiesCountryDataDiscriminationDiseaseDropsDrug usageEconomicsEnrollmentEnsureFoodGeneral PopulationGovernmentHIVHIV InfectionsHIV SeronegativityHIV SeropositivityHIV riskHIV/HCVHarm ReductionHealthHealth Services AccessibilityHealthcare SystemsHepatitis CHepatitis C ViremiaHot SpotIndividualInfectionInjecting drug userInterviewKenyaLaboratoriesLung diseasesMeasuresMethadoneMorbidity - disease rateNatural HistoryNeedlesNoseOutcomeParentsParticipantPatient RecruitmentsPatternPersonal SatisfactionPharmaceutical PreparationsPhylogenetic AnalysisPolymerase Chain ReactionPopulationPopulation ControlPopulation DensityPovertyPrevalencePreventionPublic HealthReportingResearchResearch InfrastructureRiskRisk FactorsSamplingServicesShipsSiteSocial DistanceSocial NetworkSpecimenSwabSymptomsSyringesTarget PopulationsTestingTimeViralViremiaVirusVisitVulnerable PopulationsWomanaddictionadverse outcomeantiretroviral therapybaseclinical carecohortcomorbidityexperiencefollow-upgenome sequencinghealth care availabilityhealth care servicehigh riskhousing instabilityimprovedinfection rateinjection drug useinnovationintervention programmenmethadone clinic/centermortalitypandemic diseasepeerpreventrecruitrespiratory virusresponsescreeningseropositiveservice deliverysocialsocial stigmasocioeconomicsstudy populationtransmission processuptakeviral transmission
项目摘要
ABSTRACT
In sub-Saharan Africa and globally, many persons who inject drugs (PWID) are living with undiagnosed or
untreated HIV, experience high levels of poverty, food and housing instability, and discrimination, and have
increased risk for health conditions that contribute to worse outcomes from COVID-19. It is also more challenging
for PWID to access healthcare when services have been limited by lockdowns and measures to ensure social
distancing to prevent spread of respiratory viruses, such as SARS-CoV-2. We propose to recruit and follow a
cohort of 500 HIV-positive and 500 HIV-negative PWID and their partners, many of whom also have hepatitis C,
to determine whether poorly controlled HIV infection, active drug use and other HIV- and PWID-specific risk
factors result in increased likelihood of COVID-19 acquisition, viral transmission, symptomatic disease and
poor clinical outcomes (AIM 1). We will also define transmission dynamics through phylogenetic analyses
of SAR-CoV-2 sequences from symptomatic PWID (AIM 2) and determine whether HIV care and harm
reduction service delivery disruptions are associated with poor compliance to ART and methadone, HIV
viremia and other adverse outcomes (AIM 3). Our proposal is innovative in how it reaches PWID and partners
using peer educators, employs targeted testing and symptom screening in this high-risk Kenyan population, and
defines COVID-19 transmission within and beyond local networks using phylogenetics. Participant recruitment
and enrollment will take place in drop-in centers and methadone clinics in Nairobi, Mombasa and Kilifi, Kenya
and follow-up visits will occur monthly for 6 months. In addition to collecting interview data and blood for SARS-
CoV-2 antibodies, we will ask participants who have symptoms consistent with COVID-19 at any of the 7 visits
to self-collect a nasal swab specimen for SARS-CoV-2 polymerase chain reaction (PCR), followed by genome
sequencing if positive. Laboratory assays for antibody and viral PCR testing will be conducted in Nairobi and
positive specimens will be shipped to Seattle for sequencing and phylogenetic analysis. We anticipate that our
results will highlight the need for targeted testing among PWID and inform interventions and programs for HIV
and addiction care and treatment across the globe for similar marginalized populations when confronted with
COVID-19 and other public health crises.
抽象的
在撒哈拉以南非洲和全球范围内,许多注射吸毒者 (PWID) 都生活在未确诊或感染的状态下。
未经治疗的艾滋病毒,经历高度贫困、粮食和住房不稳定以及歧视,并且
健康状况风险增加,导致 COVID-19 导致更糟糕的结果。也更具挑战性
当服务因封锁和确保社交的措施而受到限制时,注射吸毒者能否获得医疗保健
保持距离以防止呼吸道病毒(例如 SARS-CoV-2)的传播。我们建议招募并遵循
由 500 名 HIV 阳性和 500 名 HIV 阴性吸毒者及其伴侣组成的队列,其中许多人还患有丙型肝炎,
确定艾滋病毒感染控制不良、主动吸毒以及其他艾滋病毒和吸毒者特有的风险
导致感染 COVID-19、病毒传播、症状性疾病和感染的可能性增加的因素
临床结果不佳(AIM 1)。我们还将通过系统发育分析来定义传播动力学
来自有症状的吸毒者 (AIM 2) 的 SAR-CoV-2 序列,并确定 HIV 护理和伤害是否
减少服务提供中断与抗逆转录病毒疗法和美沙酮、艾滋病毒依从性差有关
病毒血症和其他不良后果(AIM 3)。我们的提案在如何影响注射吸毒者和合作伙伴方面具有创新性
利用同伴教育者,对肯尼亚高危人群进行有针对性的测试和症状筛查,以及
使用系统发育学定义了本地网络内外的 COVID-19 传播。参与者招募
登记将在肯尼亚内罗毕、蒙巴萨和基利菲的临时中心和美沙酮诊所进行
每月进行一次随访,为期 6 个月。除了收集SARS的采访资料和血液之外——
CoV-2 抗体,我们将询问在 7 次就诊中任何一次出现与 COVID-19 一致症状的参与者
自行收集鼻拭子样本进行 SARS-CoV-2 聚合酶链反应 (PCR),然后进行基因组检测
如果阳性则进行测序。抗体和病毒 PCR 检测的实验室分析将在内罗毕和
阳性标本将被运往西雅图进行测序和系统发育分析。我们预计我们的
结果将强调对吸毒者进行有针对性的检测的必要性,并为艾滋病毒干预措施和计划提供信息
以及在全球范围内为类似的边缘化人群提供的成瘾护理和治疗
COVID-19 和其他公共卫生危机。
项目成果
期刊论文数量(12)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Assisted Partner Services for People Who Inject Drugs: Index Characteristics Associated With Untreated HIV in Partners.
- DOI:10.1097/qai.0000000000003062
- 发表时间:2022-11-01
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Characteristics associated with HIV and hepatitis C seroprevalence among sexual and injecting partners of HIV positive persons who inject drugs in Nairobi and coastal Kenya.
- DOI:10.1186/s12879-022-07036-8
- 发表时间:2022-01-21
- 期刊:
- 影响因子:3.7
- 作者:Sambai BC;Kingston H;Monroe-Wise A;Mbogo L;Juma E;Ludwig-Barron N;Guthrie BL;Bukusi D;Chohan BH;Scott J;Bosire R;Dunbar M;Macharia P;Masyuko S;Sinkele W;Herbeck JT;Farquhar C
- 通讯作者:Farquhar C
Prevalence and correlates of violence among sexual and injecting partners of people who inject drugs living with HIV in Kenya: a cross-sectional study.
- DOI:10.1186/s12954-023-00895-7
- 发表时间:2023-11-02
- 期刊:
- 影响因子:4.4
- 作者:Aung, Sai Win Kyaw Htet;Kingston, Hanley;Mbogo, Loice W.;Sambai, Betsy;Monroe-Wise, Aliza;Ludwig-Barron, Natasha T.;Bukusi, David;Sinkele, William;Gitau, Esther;Masyuko, Sarah;Herbeck, Joshua T.;Farquhar, Carey;Guthrie, Brandon L.
- 通讯作者:Guthrie, Brandon L.
Factors influencing HIV-1 phylogenetic clustering.
影响 HIV-1 系统发育聚类的因素。
- DOI:10.1097/coh.0000000000000540
- 发表时间:2019
- 期刊:
- 影响因子:4.1
- 作者:Junqueira,DennisM;Sibisi,Zandile;Wilkinson,Eduan;deOliveira,Tulio
- 通讯作者:deOliveira,Tulio
Occupational roles and risks of community-embedded peer educators providing HIV, hepatitis C and harm reduction services to persons who inject drugs in Nairobi, Kenya.
- DOI:10.1371/journal.pone.0278210
- 发表时间:2022
- 期刊:
- 影响因子:3.7
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CAREY FARQUHAR其他文献
CAREY FARQUHAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CAREY FARQUHAR', 18)}}的其他基金
Subclinical cardiac dysfunction after hypertensive disorders in pregnancy
妊娠期高血压疾病后的亚临床心功能不全
- 批准号:
10002116 - 财政年份:2019
- 资助金额:
$ 15.22万 - 项目类别:
IMPLEMENTING ASSISTED PARTNER SERVICES TO HIV TEST AND TREAT MEN IN WESTERN KENYA
为肯尼亚西部的男性实施艾滋病毒检测和治疗的辅助合作伙伴服务
- 批准号:
9797235 - 财政年份:2017
- 资助金额:
$ 15.22万 - 项目类别:
Integrating Assisted Partner Services and Phylogenetics for HIV and HCV Prevention
整合辅助合作伙伴服务和系统发育学以预防 HIV 和 HCV
- 批准号:
10086117 - 财政年份:2017
- 资助金额:
$ 15.22万 - 项目类别:
Implementing Assisted Partner Services to HIV Test and Treat Men in Western Kenya
在肯尼亚西部实施艾滋病毒检测和治疗男性辅助合作伙伴服务
- 批准号:
9407079 - 财政年份:2017
- 资助金额:
$ 15.22万 - 项目类别:
Implementing Assisted Partner Services to HIV Test and Treat Men in Western Kenya
在肯尼亚西部实施艾滋病毒检测和治疗男性辅助合作伙伴服务
- 批准号:
10155081 - 财政年份:2017
- 资助金额:
$ 15.22万 - 项目类别:
Predicting Early Cardiovascular Risk among HIV-Infected and Uninfected Kenyan Adults
预测感染艾滋病毒和未感染艾滋病毒的肯尼亚成年人的早期心血管风险
- 批准号:
9354370 - 财政年份:2016
- 资助金额:
$ 15.22万 - 项目类别:
Predicting Early Cardiovascular Risk among HIV-Infected and Uninfected Kenyan Adults
预测感染艾滋病毒和未感染艾滋病毒的肯尼亚成年人的早期心血管风险
- 批准号:
9231919 - 财政年份:2016
- 资助金额:
$ 15.22万 - 项目类别:
Women and HIV: Translation of Research into Practice
妇女与艾滋病毒:研究转化为实践
- 批准号:
9283645 - 财政年份:2015
- 资助金额:
$ 15.22万 - 项目类别:
Women and HIV: Translation of Research into Practice
妇女与艾滋病毒:研究转化为实践
- 批准号:
9488546 - 财政年份:2015
- 资助金额:
$ 15.22万 - 项目类别:
Improving the HIV Care Cascade in Kenya through Implementation Science Training
通过实施科学培训改善肯尼亚的艾滋病毒护理梯级
- 批准号:
10462025 - 财政年份:2013
- 资助金额:
$ 15.22万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 15.22万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 15.22万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 15.22万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 15.22万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 15.22万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 15.22万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 15.22万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 15.22万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 15.22万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 15.22万 - 项目类别:














{{item.name}}会员




